[go: up one dir, main page]

HK8994A - Medicament for treatment of pregnancy-induced hypertension - Google Patents

Medicament for treatment of pregnancy-induced hypertension Download PDF

Info

Publication number
HK8994A
HK8994A HK89/94A HK8994A HK8994A HK 8994 A HK8994 A HK 8994A HK 89/94 A HK89/94 A HK 89/94A HK 8994 A HK8994 A HK 8994A HK 8994 A HK8994 A HK 8994A
Authority
HK
Hong Kong
Prior art keywords
pregnancy
medicament
induced hypertension
treatment
eicosapentaonate
Prior art date
Application number
HK89/94A
Inventor
John England Michael
Original Assignee
Efamol Holdings Plc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings Plc. filed Critical Efamol Holdings Plc.
Publication of HK8994A publication Critical patent/HK8994A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A substance or composition for combatting pregnancy-induced hypertension comprises as an active ingredient a pharmaceutically effective and acceptable amount of eicosapentaenoic acid or its pharmaceutically acceptable salts or derivatives containing the eicosapentaonate group.
HK89/94A 1986-11-13 1994-01-21 Medicament for treatment of pregnancy-induced hypertension HK8994A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA868623 1986-11-13

Publications (1)

Publication Number Publication Date
HK8994A true HK8994A (en) 1994-02-04

Family

ID=25578634

Family Applications (1)

Application Number Title Priority Date Filing Date
HK89/94A HK8994A (en) 1986-11-13 1994-01-21 Medicament for treatment of pregnancy-induced hypertension

Country Status (3)

Country Link
AU (1) AU601238B2 (en)
GB (1) GB2197199B (en)
HK (1) HK8994A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
DK0661049T3 (en) * 1993-12-31 2000-02-14 Univ Limburg Use of Essential Fatty Acid Compositions
EP2295529B2 (en) 2002-07-11 2022-05-18 Basf As Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use
SE0202188D0 (en) 2002-07-11 2002-07-11 Pronova Biocare As A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097602A (en) * 1974-11-29 1978-06-27 Silver Melvin J Method of inhibiting blood platelet aggregation
GB1604554A (en) * 1978-05-26 1981-12-09 Dyerberg J Pharmaceutical and food formulations
GB2033745B (en) * 1978-05-26 1983-08-17 Wellcome Found Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
JPS5813541A (en) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd Cyclodextrin clathrate compound of eicosapentaenoic acid or docosahexaenoic acid
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
CA1225597A (en) * 1982-09-22 1987-08-18 Jakobus Booyens Prophylactic substance or composition
JPS6034156A (en) * 1983-08-08 1985-02-21 Hayashibara Biochem Lab Inc Eicosapentaenoic acid clathrate compound and food and drink containing the same
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
AU4595985A (en) * 1984-08-10 1986-02-13 Sentrachem Limited Cancer treatment
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
GB8524276D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
LU86220A1 (en) * 1985-12-19 1987-07-24 Chimicasa Gmbh METHOD FOR PRODUCING A PHARMACEUTICAL PREPARATIVE LOWERING THE CHOLESTERIN AND TRIGLYCERIDE CONTENT

Also Published As

Publication number Publication date
AU601238B2 (en) 1990-09-06
GB2197199B (en) 1991-04-03
AU8113787A (en) 1988-05-19
GB2197199A (en) 1988-05-18
GB8726517D0 (en) 1987-12-16

Similar Documents

Publication Publication Date Title
TW234691B (en)
CA2009593A1 (en) Medicament containing dihydrolipoic acid as active substance
ATE130758T1 (en) MEDICINAL PRODUCTS FOR INTRANASAL ADMINISTRATION CONTAINING KETOROLAC R.
AU4697393A (en) Pharmaceutical and/or cosmetic preparation and the use of the preparation
IE790756L (en) Cerebral therapeutic agent
IE871981L (en) Programmed release formulation.
IE894048L (en) New therapeutically active compound and a process for its¹preparation
IE873125L (en) Benzimidazole derivatives
EG17609A (en) Process for preparation of therapeutic agents from derivatives of propoimic acid.
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
AU4538489A (en) Pharmaceutical compositions
AU1277792A (en) Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts
IE781032L (en) Pharmaceutical compositions
IE894050L (en) Compound with gastric acid inhibitory effect and process for¹its preparation
UA40636C2 (en) pharmaceutical composition containing, as the active ingredient, an association of acetylsalicylic acid and metoclopramide, pharmaceutical medication in the form of powder and method for its preparation
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
EP0104768A3 (en) Oral compositions comprising ng-acyl derivatives of arginine
EP0199117A3 (en) New therapeutical use of phosphocreatine
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
NO891114D0 (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARAKIDONIC ACID DERIVATIVES.
HK8994A (en) Medicament for treatment of pregnancy-induced hypertension
AU610175B2 (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
WO1999056734A3 (en) Transdermal therapeutic system for the administration of candesartan
EP0351876A3 (en) Composition for potentiating vaccination effect
NO172491C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,3-DIOXANE-ALCOHIC ACID DERIVATIVES

Legal Events

Date Code Title Description
NR Patent deemed never to have been added to the register under section 13(7) of patents (transitional arrangements) rules